Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

EMN vs LIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EMN
Eastman Chemical Company

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$8.66B
5Y Perf.+11.3%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$232.56B
5Y Perf.+148.0%

EMN vs LIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EMN logoEMN
LIN logoLIN
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$8.66B$232.56B
Revenue (TTM)$8.64B$34.66B
Net Income (TTM)$399M$7.13B
Gross Margin19.8%46.0%
Operating Margin9.4%28.8%
Forward P/E12.8x28.1x
Total Debt$5.08B$26.99B
Cash & Equiv.$566M$5.06B

EMN vs LINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EMN
LIN
StockMay 20May 26Return
Eastman Chemical Co… (EMN)100111.3+11.3%
Linde plc (LIN)100248.0+148.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: EMN vs LIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Eastman Chemical Company is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
EMN
Eastman Chemical Company
The Income Pick

EMN is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 12 yrs, beta 1.36, yield 4.4%
  • Beta 1.36, yield 4.4%, current ratio 1.37x
  • Lower P/E (12.8x vs 28.1x)
Best for: income & stability and defensive
LIN
Linde plc
The Growth Play

LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
  • 376.9% 10Y total return vs EMN's 36.1%
  • Lower volatility, beta 0.24, Low D/E 67.9%, current ratio 0.88x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthLIN logoLIN3.0% revenue growth vs EMN's -6.7%
ValueEMN logoEMNLower P/E (12.8x vs 28.1x)
Quality / MarginsLIN logoLIN20.6% margin vs EMN's 4.6%
Stability / SafetyLIN logoLINBeta 0.24 vs EMN's 1.36, lower leverage
DividendsEMN logoEMN4.4% yield, 12-year raise streak, vs LIN's 1.2%
Momentum (1Y)LIN logoLIN+13.6% vs EMN's +3.9%
Efficiency (ROA)LIN logoLIN8.3% ROA vs EMN's 2.6%, ROIC 11.3% vs 6.7%

EMN vs LIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EMNEastman Chemical Company
FY 2025
Advanced Materials
33.0%$2.9B
Additives And Functional Products
33.0%$2.9B
Chemical Intermediates
22.0%$1.9B
Fibers
12.0%$1.1B
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B

EMN vs LIN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLINLAGGINGEMN

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 6 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 4.0x EMN's $8.6B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to EMN's 4.6%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
RevenueTrailing 12 months$8.6B$34.7B
EBITDAEarnings before interest/tax$1.2B$12.1B
Net IncomeAfter-tax profit$399M$7.1B
Free Cash FlowCash after capex$498M$5.1B
Gross MarginGross profit ÷ Revenue+19.8%+46.0%
Operating MarginEBIT ÷ Revenue+9.4%+28.8%
Net MarginNet income ÷ Revenue+4.6%+20.6%
FCF MarginFCF ÷ Revenue+5.8%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year-4.9%+8.2%
EPS Growth (YoY)Latest quarter vs prior year-40.8%+13.4%
LIN leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

EMN leads this category, winning 6 of 7 comparable metrics.

At 18.5x trailing earnings, EMN trades at a 46% valuation discount to LIN's 34.4x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs EMN's 5.75x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
Market CapShares × price$8.7B$232.6B
Enterprise ValueMkt cap + debt − cash$13.2B$254.5B
Trailing P/EPrice ÷ TTM EPS18.47x34.40x
Forward P/EPrice ÷ next-FY EPS est.12.85x28.12x
PEG RatioP/E ÷ EPS growth rate5.75x1.36x
EV / EBITDAEnterprise value multiple9.12x20.04x
Price / SalesMarket cap ÷ Revenue0.99x6.84x
Price / BookPrice ÷ Book value/share1.45x5.92x
Price / FCFMarket cap ÷ FCF20.43x45.70x
EMN leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

LIN leads this category, winning 7 of 9 comparable metrics.

LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $7 for EMN. LIN carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMN's 0.84x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs EMN's 5/9, reflecting solid financial health.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
ROE (TTM)Return on equity+6.7%+17.8%
ROA (TTM)Return on assets+2.6%+8.3%
ROICReturn on invested capital+6.7%+11.3%
ROCEReturn on capital employed+7.5%+13.0%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.84x0.68x
Net DebtTotal debt minus cash$4.5B$21.9B
Cash & Equiv.Liquid assets$566M$5.1B
Total DebtShort + long-term debt$5.1B$27.0B
Interest CoverageEBIT ÷ Interest expense2.22x34.52x
LIN leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LIN leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $7,381 for EMN. Over the past 12 months, LIN leads with a +13.6% total return vs EMN's +3.9%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs EMN's 1.9% — a key indicator of consistent wealth creation.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
YTD ReturnYear-to-date+19.0%+17.3%
1-Year ReturnPast 12 months+3.9%+13.6%
3-Year ReturnCumulative with dividends+6.0%+41.9%
5-Year ReturnCumulative with dividends-26.2%+78.1%
10-Year ReturnCumulative with dividends+36.1%+376.9%
CAGR (3Y)Annualised 3-year return+1.9%+12.4%
LIN leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than EMN's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs EMN's 90.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
Beta (5Y)Sensitivity to S&P 5001.36x0.24x
52-Week HighHighest price in past year$84.18$521.28
52-Week LowLowest price in past year$56.11$387.78
% of 52W HighCurrent price vs 52-week peak+90.0%+96.3%
RSI (14)Momentum oscillator 0–10062.850.6
Avg Volume (50D)Average daily shares traded1.5M2.3M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

EMN leads this category, winning 2 of 2 comparable metrics.

Wall Street rates EMN as "Buy" and LIN as "Buy". Consensus price targets imply 7.5% upside for LIN (target: $540) vs 2.0% for EMN (target: $77). For income investors, EMN offers the higher dividend yield at 4.35% vs LIN's 1.20%.

MetricEMN logoEMNEastman Chemical …LIN logoLINLinde plc
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$77.29$539.71
# AnalystsCovering analysts3528
Dividend YieldAnnual dividend ÷ price+4.4%+1.2%
Dividend StreakConsecutive years of raises126
Dividend / ShareAnnual DPS$3.30$6.00
Buyback YieldShare repurchases ÷ mkt cap+1.2%+2.0%
EMN leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMN leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallLinde plc (LIN)Leads 4 of 6 categories
Loading custom metrics...

EMN vs LIN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is EMN or LIN a better buy right now?

For growth investors, Linde plc (LIN) is the stronger pick with 3.

0% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 5x trailing P/E (12. 8x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EMN or LIN?

On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.

5x versus Linde plc at 34. 4x. On forward P/E, Eastman Chemical Company is actually cheaper at 12. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Eastman Chemical Company's 4. 00x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — EMN or LIN?

Over the past 5 years, Linde plc (LIN) delivered a total return of +78.

1%, compared to -26. 2% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: LIN returned +376. 9% versus EMN's +36. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EMN or LIN?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Eastman Chemical Company's 1. 36β — meaning EMN is approximately 465% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 84% for Eastman Chemical Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — EMN or LIN?

By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.

0% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -46. 5% for Eastman Chemical Company. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EMN or LIN?

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus 5. 4% for Eastman Chemical Company — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 10. 6% for EMN. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EMN or LIN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Eastman Chemical Company's 4. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Eastman Chemical Company (EMN) trades at 12. 8x forward P/E versus 28. 1x for Linde plc — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 5% to $539. 71.

08

Which pays a better dividend — EMN or LIN?

All stocks in this comparison pay dividends.

Eastman Chemical Company (EMN) offers the highest yield at 4. 4%, versus 1. 2% for Linde plc (LIN).

09

Is EMN or LIN better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, EMN: +36. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EMN and LIN?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: EMN is a small-cap income-oriented stock; LIN is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

EMN

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Dividend Yield > 1.7%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EMN and LIN on the metrics below

Revenue Growth>
%
(EMN: -4.9% · LIN: 8.2%)
Net Margin>
%
(EMN: 4.6% · LIN: 20.6%)
P/E Ratio<
x
(EMN: 18.5x · LIN: 34.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.